What is the new meningitis vaccine and what does it do? Last month the Food and Drug Administration approved a new pentavalent vaccine, designed to cover all five strains of meningitis – ACWY and B.

Related: Meningitis B Vaccine Will be Imported to Fight Ivy League Outbreak. But only about a third of U.S. teens got both recommended doses of meningitis ACWY vaccine in 2015 and just 81 percent ...

In addition, those aged 2 years or older with HIV and not previously vaccinated are recommended to receive a two-dose primary series of meningitis ACWY conjugate vaccine (MenACWY). Those News News ...

A vaccination campaign against meningococcal B bacteria has been initiated in the Chambéry and Lyon-East regions of France following an increase in infections with a new variant ... Meningitis ACWY.

Physician John Johnson encourages use of a new vaccine that will work against all five strains of meningitis, noting the need to protect adolescents from the ... The ACWY vaccine is now ...

Meningitis B vaccine advocate Patti Wukovits and daughter Kimberly Coffey, then 15. Kimberly died of the disease at age 17 in 2012. Wukovits says parents need to ask their children’s doctors ...

Now, two separate vaccines are needed to be fully immunized against the five main types of meningococcal bacteria (A, B, C, W, Y). Both of our girls had received their MenACWY meningitis vaccines ...

January 8, 2008 — A new meningitis vaccine may be better able to produce immunity in infants than the current meningococcal tetravalent glycoconjugate vaccine, according to the results of a ...

A meningitis vaccine is delivered to a patient, April 15, 2013. Health officials are urging school leavers, particularly those preparing to go to university or college, to get themselves vaccinated.

That’s right, the new meningitis ACWY vaccine, known as MenACWY, is being offered to all students under 25 attending university for the first time. Q. That’s a funny name.

The Kansas Department of Health and Environment proposed adding vaccination requirements for meningitis and hepatitis A to its regulations earlier this year followed by a 60-day public comment period.